Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Rapid Microbiology Testing Market by Method (Viability-based, Cellular Component-based, Growth-based, Nucleic Acid-based, Other Rapid Microbiology Testing Methods (micro-electrical-mechanical systems (MEMS) and optical spectroscopy)), by Application (Clinical Disease Diagnosis, Food Beverage Testing, Environmental Testing, Pharmaceutical Biological Drug Testing, Cosmetics Personal Care Products Testing, Research Applications, Other Applications (chemicals, paints, and biofuels)) and by End Users (Diagnostic Laboratories Hospitals, Pharmaceutical Biotechnology Companies, Food Beverage Companies, Contract Research Organizations, Other End Users (environmental study agencies, NGOs, academic institutes, cosmetics and personal care testing industry, and research laboratories)): Global Opportunity Analysis and Industry Forecast, 2023-2032

A09145

Pages: NA

Charts: NA

Tables: NA

Rapid Microbiology Testing Market is expected to grow in upcoming years due to factors such as rise in prevalence of infectious diseases and increase in awareness about rapid microbiology testing among the people.

Rapid Microbiology testing is carried out for early identification of microbial risks, monitoring of critical control points in real time, manufacturing processes, contribution for improvement, enhancement in safety profile of products and decrease in overall costs of quality procedures. The technique of rapid microbiology testing is used in research activity, drug development and other diagnosis. rapid detection of diseases like malaria and tuberculosis is done with the help of rapid microbiology testing. Rapid microbiology testing helps in assisting and managing low respiratory tract infection. These tests provide faster results as compared to traditional culture- based tests.

COVID-19 scenario analysis:

At the early phase of COVID-19 pandemic, there was no availability of specific diagnostic tests to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global market. These players achieved edge over other diagnostics players capitalizing the opportunity from demand for COVID-19 diagnostic tests, which, in turn, helps them in maintaining their revenues in such a crisis. Considering these factors, COVID -19 is expected to have significant impact on Rapid Microbiology Testing Market.

Top Impacting factors:

  • Factors such as rise in food safety concerns and increase in prevalence of infectious diseases are expected to rise the market growth of rapid microbiology testing in upcoming years.
  • Increase in funding and research grants by public and private investors are the major factors rising the growth for rapid microbiology testing market.
  • Rise in adoption of microbiology testing of diagnosis of various infectious diseases in humans is expected to boost the market growth over the forecast period.
  • Increasing emphasis on effective and early diagnosis of diseases and technological advancements made in the field are expected to rise the rapid microbiological testing market growth.
  • However, high costs associated with the tests and unfavorable compensation policies are the factors which can hamper the growth of microbiological testing market up to some extent over the forecast period.

New Product Launch / News:

  • In February 2019, bioMérieux, a global player in in vitro diagnostics and world leader in food microbiology testing, announced the acquisition of Invisible Sentinel Inc. This company develops, manufactures and markets innovative and user-friendly molecular diagnostic tools for the rapid, accurate and reliable detection of pathogens and spoilage organisms in food and beverage.
  • In 2018, LuminUltra acquired aqua-tools’ Rapid Microbial Solutions division. This added the B-QUA product line for ballast water obedience monitoring in LuminUltra’s portfolio.

Key benefits of the report:

  • This study presents the analytical depiction of the Rapid Microbiology Testing Market along with the current trends and future estimations to determine the investments.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Rapid Microbiology Testing Market share.
  • The current market is quantitatively analyzed to highlight the Rapid Microbiology Testing Market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed Rapid Microbiology Testing Market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Rapid Microbiology Testing Market Report:

  • What are the leading market players active in Rapid Microbiology Testing Market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?
  • What Segments and region will drive the market growth & why?

 Key Market Segments

  • By Method
    • Viability-based
    • Cellular Component-based
    • Growth-based
    • Nucleic Acid-based
    • Other Rapid Microbiology Testing Methods (micro-electrical-mechanical systems (MEMS) and optical spectroscopy)
  • By Application
    • Clinical Disease Diagnosis
    • Food & Beverage Testing
    • Environmental Testing
    • Pharmaceutical & Biological Drug Testing
    • Cosmetics & Personal Care Products Testing
    • Research Applications
    • Other Applications (chemicals, paints, and biofuels)
  • By End Users
    • Diagnostic Laboratories & Hospitals
    • Pharmaceutical & Biotechnology Companies
    • Food & Beverage Companies
    • Contract Research Organizations
    • Other End Users (environmental study agencies, NGOs, academic institutes, cosmetics and personal care testing industry, and research laboratories)
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • bioMérieux
  • MERLIN
  • Bioanalyse
  • Thermo Fisher Scientific Inc.
  • Merck Group
  • Synbiosis
  • Zhuhai DL Biotech.
  • Liofilchem
  • Creative Diagnostics
  • Bio-Rad
  • Danaher Corporation
  • Hi-Media

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Method

    • 4.2. Viability-based

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Cellular Component-based

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Growth-based

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Nucleic Acid-based

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Other Rapid Microbiology Testing Methods (micro-electrical-mechanical Systems (MEMS) And Optical Spectroscopy)

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Clinical Disease Diagnosis

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Food And Beverage Testing

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Environmental Testing

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Pharmaceutical And Biological Drug Testing

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Cosmetics And Personal Care Products Testing

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Research Applications

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

    • 5.8. Other Applications (chemicals, Paints, And Biofuels)

      • 5.8.1. Key Market Trends, Growth Factors and Opportunities

      • 5.8.2. Market Size and Forecast, By Region

      • 5.8.3. Market Share Analysis, By Country

  • CHAPTER 6: RAPID MICROBIOLOGY TESTING MARKET, BY END USERS

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End Users

    • 6.2. Diagnostic Laboratories And Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Pharmaceutical And Biotechnology Companies

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Food And Beverage Companies

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Contract Research Organizations

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Other End Users (environmental Study Agencies, NGOs, Academic Institutes, Cosmetics And Personal Care Testing Industry, And Research Laboratories)

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

  • CHAPTER 7: RAPID MICROBIOLOGY TESTING MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Method

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End Users

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Rapid Microbiology Testing Market

        • 7.2.6.1. Market Size and Forecast, By Method
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By End Users

      • 7.2.7. Canada Rapid Microbiology Testing Market

        • 7.2.7.1. Market Size and Forecast, By Method
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By End Users

      • 7.2.8. Mexico Rapid Microbiology Testing Market

        • 7.2.8.1. Market Size and Forecast, By Method
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By End Users

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Method

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End Users

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Rapid Microbiology Testing Market

        • 7.3.6.1. Market Size and Forecast, By Method
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By End Users

      • 7.3.7. Germany Rapid Microbiology Testing Market

        • 7.3.7.1. Market Size and Forecast, By Method
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By End Users

      • 7.3.8. Italy Rapid Microbiology Testing Market

        • 7.3.8.1. Market Size and Forecast, By Method
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By End Users

      • 7.3.9. Spain Rapid Microbiology Testing Market

        • 7.3.9.1. Market Size and Forecast, By Method
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By End Users

      • 7.3.10. UK Rapid Microbiology Testing Market

        • 7.3.10.1. Market Size and Forecast, By Method
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By End Users

      • 7.3.11. Russia Rapid Microbiology Testing Market

        • 7.3.11.1. Market Size and Forecast, By Method
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By End Users

      • 7.3.12. Rest Of Europe Rapid Microbiology Testing Market

        • 7.3.12.1. Market Size and Forecast, By Method
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By End Users

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Method

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End Users

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Rapid Microbiology Testing Market

        • 7.4.6.1. Market Size and Forecast, By Method
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By End Users

      • 7.4.7. Japan Rapid Microbiology Testing Market

        • 7.4.7.1. Market Size and Forecast, By Method
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By End Users

      • 7.4.8. India Rapid Microbiology Testing Market

        • 7.4.8.1. Market Size and Forecast, By Method
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By End Users

      • 7.4.9. South Korea Rapid Microbiology Testing Market

        • 7.4.9.1. Market Size and Forecast, By Method
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By End Users

      • 7.4.10. Australia Rapid Microbiology Testing Market

        • 7.4.10.1. Market Size and Forecast, By Method
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By End Users

      • 7.4.11. Thailand Rapid Microbiology Testing Market

        • 7.4.11.1. Market Size and Forecast, By Method
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By End Users

      • 7.4.12. Malaysia Rapid Microbiology Testing Market

        • 7.4.12.1. Market Size and Forecast, By Method
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By End Users

      • 7.4.13. Indonesia Rapid Microbiology Testing Market

        • 7.4.13.1. Market Size and Forecast, By Method
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By End Users

      • 7.4.14. Rest of Asia Pacific Rapid Microbiology Testing Market

        • 7.4.14.1. Market Size and Forecast, By Method
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By End Users

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Method

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End Users

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Rapid Microbiology Testing Market

        • 7.5.6.1. Market Size and Forecast, By Method
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By End Users

      • 7.5.7. South Africa Rapid Microbiology Testing Market

        • 7.5.7.1. Market Size and Forecast, By Method
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By End Users

      • 7.5.8. Saudi Arabia Rapid Microbiology Testing Market

        • 7.5.8.1. Market Size and Forecast, By Method
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By End Users

      • 7.5.9. UAE Rapid Microbiology Testing Market

        • 7.5.9.1. Market Size and Forecast, By Method
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By End Users

      • 7.5.10. Argentina Rapid Microbiology Testing Market

        • 7.5.10.1. Market Size and Forecast, By Method
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By End Users

      • 7.5.11. Rest of LAMEA Rapid Microbiology Testing Market

        • 7.5.11.1. Market Size and Forecast, By Method
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By End Users

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Thermo Fisher Scientific Inc.

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Danaher Corporation

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. BioMérieux

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Bio-Rad

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Creative Diagnostics

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Merck Group

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Bioanalyse

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Hi-Media

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Liofilchem

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. MERLIN

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

    • 9.11. Synbiosis

      • 9.11.1. Company Overview

      • 9.11.2. Key Executives

      • 9.11.3. Company Snapshot

      • 9.11.4. Operating Business Segments

      • 9.11.5. Product Portfolio

      • 9.11.6. Business Performance

      • 9.11.7. Key Strategic Moves and Developments

    • 9.12. Zhuhai DL Biotech.

      • 9.12.1. Company Overview

      • 9.12.2. Key Executives

      • 9.12.3. Company Snapshot

      • 9.12.4. Operating Business Segments

      • 9.12.5. Product Portfolio

      • 9.12.6. Business Performance

      • 9.12.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL RAPID MICROBIOLOGY TESTING MARKET FOR VIABILITY-BASED, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL RAPID MICROBIOLOGY TESTING MARKET FOR CELLULAR COMPONENT-BASED, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL RAPID MICROBIOLOGY TESTING MARKET FOR GROWTH-BASED, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL RAPID MICROBIOLOGY TESTING MARKET FOR NUCLEIC ACID-BASED, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL RAPID MICROBIOLOGY TESTING MARKET FOR OTHER RAPID MICROBIOLOGY TESTING METHODS (MICRO-ELECTRICAL-MECHANICAL SYSTEMS (MEMS) AND OPTICAL SPECTROSCOPY), BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL RAPID MICROBIOLOGY TESTING MARKET FOR FOOD AND BEVERAGE TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL AND BIOLOGICAL DRUG TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS AND PERSONAL CARE PRODUCTS TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL RAPID MICROBIOLOGY TESTING MARKET FOR OTHER APPLICATIONS (CHEMICALS, PAINTS, AND BIOFUELS), BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL RAPID MICROBIOLOGY TESTING MARKET, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL RAPID MICROBIOLOGY TESTING MARKET FOR DIAGNOSTIC LABORATORIES AND HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. GLOBAL RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. GLOBAL RAPID MICROBIOLOGY TESTING MARKET FOR FOOD AND BEVERAGE COMPANIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. GLOBAL RAPID MICROBIOLOGY TESTING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. GLOBAL RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS (ENVIRONMENTAL STUDY AGENCIES, NGOS, ACADEMIC INSTITUTES, COSMETICS AND PERSONAL CARE TESTING INDUSTRY, AND RESEARCH LABORATORIES), BY REGION, 2025-2033 ($MILLION)
  • TABLE 21. GLOBAL RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 22. NORTH AMERICA RAPID MICROBIOLOGY TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 23. NORTH AMERICA RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 24. NORTH AMERICA RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 25. NORTH AMERICA RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 26. U.S. RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 27. U.S. RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 28. U.S. RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 29. CANADA RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 30. CANADA RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 31. CANADA RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 32. MEXICO RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 33. MEXICO RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 34. MEXICO RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 35. EUROPE RAPID MICROBIOLOGY TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 36. EUROPE RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 37. EUROPE RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 38. EUROPE RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 39. FRANCE RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 40. FRANCE RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 41. FRANCE RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 42. GERMANY RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 43. GERMANY RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 44. GERMANY RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 45. ITALY RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 46. ITALY RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 47. ITALY RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 48. SPAIN RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 49. SPAIN RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 50. SPAIN RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 51. UK RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 52. UK RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 53. UK RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 54. RUSSIA RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 55. RUSSIA RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 56. RUSSIA RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 57. REST OF EUROPE RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 58. REST OF EUROPE RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 59. REST OF EUROPE RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 60. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 61. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 62. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 63. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 64. CHINA RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 65. CHINA RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 66. CHINA RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 67. JAPAN RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 68. JAPAN RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 69. JAPAN RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 70. INDIA RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 71. INDIA RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 72. INDIA RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 73. SOUTH KOREA RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 74. SOUTH KOREA RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 75. SOUTH KOREA RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 76. AUSTRALIA RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 77. AUSTRALIA RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 78. AUSTRALIA RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 79. THAILAND RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 80. THAILAND RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 81. THAILAND RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 82. MALAYSIA RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 83. MALAYSIA RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 84. MALAYSIA RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 85. INDONESIA RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 86. INDONESIA RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 87. INDONESIA RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 88. REST OF ASIA PACIFIC RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 89. REST OF ASIA PACIFIC RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 90. REST OF ASIA PACIFIC RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 91. LAMEA RAPID MICROBIOLOGY TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 92. LAMEA RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 93. LAMEA RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 94. LAMEA RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 95. BRAZIL RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 96. BRAZIL RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 97. BRAZIL RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 98. SOUTH AFRICA RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 99. SOUTH AFRICA RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 100. SOUTH AFRICA RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 101. SAUDI ARABIA RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 102. SAUDI ARABIA RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 103. SAUDI ARABIA RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 104. UAE RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 105. UAE RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 106. UAE RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 107. ARGENTINA RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 108. ARGENTINA RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 109. ARGENTINA RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 110. REST OF LAMEA RAPID MICROBIOLOGY TESTING, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 111. REST OF LAMEA RAPID MICROBIOLOGY TESTING, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 112. REST OF LAMEA RAPID MICROBIOLOGY TESTING, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 113. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 114. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 115. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
  • TABLE 116. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 117. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. DANAHER CORPORATION: KEY EXECUTIVES
  • TABLE 119. DANAHER CORPORATION: COMPANY SNAPSHOT
  • TABLE 120. DANAHER CORPORATION: OPERATING SEGMENTS
  • TABLE 121. DANAHER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 122. DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 123. BIOMéRIEUX: KEY EXECUTIVES
  • TABLE 124. BIOMéRIEUX: COMPANY SNAPSHOT
  • TABLE 125. BIOMéRIEUX: OPERATING SEGMENTS
  • TABLE 126. BIOMéRIEUX: PRODUCT PORTFOLIO
  • TABLE 127. BIOMéRIEUX: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 128. BIO-RAD: KEY EXECUTIVES
  • TABLE 129. BIO-RAD: COMPANY SNAPSHOT
  • TABLE 130. BIO-RAD: OPERATING SEGMENTS
  • TABLE 131. BIO-RAD: PRODUCT PORTFOLIO
  • TABLE 132. BIO-RAD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 133. CREATIVE DIAGNOSTICS: KEY EXECUTIVES
  • TABLE 134. CREATIVE DIAGNOSTICS: COMPANY SNAPSHOT
  • TABLE 135. CREATIVE DIAGNOSTICS: OPERATING SEGMENTS
  • TABLE 136. CREATIVE DIAGNOSTICS: PRODUCT PORTFOLIO
  • TABLE 137. CREATIVE DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 138. MERCK GROUP: KEY EXECUTIVES
  • TABLE 139. MERCK GROUP: COMPANY SNAPSHOT
  • TABLE 140. MERCK GROUP: OPERATING SEGMENTS
  • TABLE 141. MERCK GROUP: PRODUCT PORTFOLIO
  • TABLE 142. MERCK GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 143. BIOANALYSE: KEY EXECUTIVES
  • TABLE 144. BIOANALYSE: COMPANY SNAPSHOT
  • TABLE 145. BIOANALYSE: OPERATING SEGMENTS
  • TABLE 146. BIOANALYSE: PRODUCT PORTFOLIO
  • TABLE 147. BIOANALYSE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 148. HI-MEDIA: KEY EXECUTIVES
  • TABLE 149. HI-MEDIA: COMPANY SNAPSHOT
  • TABLE 150. HI-MEDIA: OPERATING SEGMENTS
  • TABLE 151. HI-MEDIA: PRODUCT PORTFOLIO
  • TABLE 152. HI-MEDIA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 153. LIOFILCHEM: KEY EXECUTIVES
  • TABLE 154. LIOFILCHEM: COMPANY SNAPSHOT
  • TABLE 155. LIOFILCHEM: OPERATING SEGMENTS
  • TABLE 156. LIOFILCHEM: PRODUCT PORTFOLIO
  • TABLE 157. LIOFILCHEM: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 158. MERLIN: KEY EXECUTIVES
  • TABLE 159. MERLIN: COMPANY SNAPSHOT
  • TABLE 160. MERLIN: OPERATING SEGMENTS
  • TABLE 161. MERLIN: PRODUCT PORTFOLIO
  • TABLE 162. MERLIN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 163. SYNBIOSIS: KEY EXECUTIVES
  • TABLE 164. SYNBIOSIS: COMPANY SNAPSHOT
  • TABLE 165. SYNBIOSIS: OPERATING SEGMENTS
  • TABLE 166. SYNBIOSIS: PRODUCT PORTFOLIO
  • TABLE 167. SYNBIOSIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 168. ZHUHAI DL BIOTECH.: KEY EXECUTIVES
  • TABLE 169. ZHUHAI DL BIOTECH.: COMPANY SNAPSHOT
  • TABLE 170. ZHUHAI DL BIOTECH.: OPERATING SEGMENTS
  • TABLE 171. ZHUHAI DL BIOTECH.: PRODUCT PORTFOLIO
  • TABLE 172. ZHUHAI DL BIOTECH.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SEGMENTATION
  • FIGURE 2. GLOBAL RAPID MICROBIOLOGY TESTING MARKET
  • FIGURE 3. SEGMENTATION RAPID MICROBIOLOGY TESTING MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN RAPID MICROBIOLOGY TESTING MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALRAPID MICROBIOLOGY TESTING MARKET
  • FIGURE 11. RAPID MICROBIOLOGY TESTING MARKET SEGMENTATION, BY BY METHOD
  • FIGURE 12. RAPID MICROBIOLOGY TESTING MARKET FOR VIABILITY-BASED, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. RAPID MICROBIOLOGY TESTING MARKET FOR CELLULAR COMPONENT-BASED, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. RAPID MICROBIOLOGY TESTING MARKET FOR GROWTH-BASED, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. RAPID MICROBIOLOGY TESTING MARKET FOR NUCLEIC ACID-BASED, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. RAPID MICROBIOLOGY TESTING MARKET FOR OTHER RAPID MICROBIOLOGY TESTING METHODS (MICRO-ELECTRICAL-MECHANICAL SYSTEMS (MEMS) AND OPTICAL SPECTROSCOPY), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. RAPID MICROBIOLOGY TESTING MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 18. RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. RAPID MICROBIOLOGY TESTING MARKET FOR FOOD AND BEVERAGE TESTING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL AND BIOLOGICAL DRUG TESTING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. RAPID MICROBIOLOGY TESTING MARKET FOR COSMETICS AND PERSONAL CARE PRODUCTS TESTING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. RAPID MICROBIOLOGY TESTING MARKET FOR OTHER APPLICATIONS (CHEMICALS, PAINTS, AND BIOFUELS), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. RAPID MICROBIOLOGY TESTING MARKET SEGMENTATION, BY BY END USERS
  • FIGURE 26. RAPID MICROBIOLOGY TESTING MARKET FOR DIAGNOSTIC LABORATORIES AND HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 27. RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 28. RAPID MICROBIOLOGY TESTING MARKET FOR FOOD AND BEVERAGE COMPANIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 29. RAPID MICROBIOLOGY TESTING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 30. RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS (ENVIRONMENTAL STUDY AGENCIES, NGOS, ACADEMIC INSTITUTES, COSMETICS AND PERSONAL CARE TESTING INDUSTRY, AND RESEARCH LABORATORIES), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 31. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 32. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 33. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 34. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 35. COMPETITIVE DASHBOARD
  • FIGURE 36. COMPETITIVE HEATMAP: RAPID MICROBIOLOGY TESTING MARKET
  • FIGURE 37. TOP PLAYER POSITIONING, 2024
  • FIGURE 38. THERMO FISHER SCIENTIFIC INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. DANAHER CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. DANAHER CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. DANAHER CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. BIOMéRIEUX: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. BIOMéRIEUX: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. BIOMéRIEUX: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. BIO-RAD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. BIO-RAD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. BIO-RAD: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. CREATIVE DIAGNOSTICS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. CREATIVE DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. CREATIVE DIAGNOSTICS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. MERCK GROUP: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. MERCK GROUP: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. MERCK GROUP: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. BIOANALYSE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. BIOANALYSE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. BIOANALYSE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 59. HI-MEDIA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 60. HI-MEDIA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 61. HI-MEDIA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 62. LIOFILCHEM: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 63. LIOFILCHEM: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 64. LIOFILCHEM: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 65. MERLIN: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 66. MERLIN: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 67. MERLIN: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 68. SYNBIOSIS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 69. SYNBIOSIS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 70. SYNBIOSIS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 71. ZHUHAI DL BIOTECH.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 72. ZHUHAI DL BIOTECH.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 73. ZHUHAI DL BIOTECH.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Rapid Microbiology Testing Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved